- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sotorasib is an oral inhibitor targeting KRASG12C mutations, primarily used to treat non-small cell lung cancer and colorectal cancer with spec...
Sotorasib, as a KRASG12C mutation specific inhibitor, has shown significant efficacy in the treatment of non-small cell lung cancer and colorec...
Sotorasib has not yet been officially listed in Chinese Mainland. Patients need to obtain it through overseas channels, but they should pay att...
The daily dosage of Ibrutinib should be adjusted according to the indications, age, and liver function status. It is usually taken orally once ...
Ibrutinib is a targeted therapy drug mainly used to treat various B-cell malignancies and chronic graft-versus-host disease. Its indications in...
Epclusa, as a treatment drug for hepatitis C virus (HCV), the duration of its course of treatment needs to be personalized according to the pat...
Epclusa is a compound formulation composed of sofosbuvir and velpatasvir, specifically designed for the treatment of chronic hepatitis C virus ...
Dasatinib, as a tyrosine kinase inhibitor, has contraindications mainly related to specific disease states, drug interactions, and special popu...
Epclusa is a compound formulation composed of Sofosbuvir and Velpatasvir. It is the world's first oral antiviral drug for the full genotype hep...
The recommended medication time for Epclusa is fixed daily and can be taken on an empty stomach or after a meal, but attention should be paid t...
